STE
BioSig Technologies, Inc. (STEX) Q4 2025 Annual Earnings
STEX·Reported March 31, 2026
Diluted EPS came in at $-0.03 (+52.5% YoY).
Diluted EPS
$-0.03met estimate
Consensus: $-0.03
Financial Snapshot
Trailing eight quarters through Q4 2025
Q4 2025 Earnings FAQ
Common questions about BioSig Technologies, Inc.'s Q4 2025 earnings report.
BioSig Technologies, Inc. (STEX) reported Q4 2025 earnings on March 31, 2026.
BioSig Technologies, Inc. reported diluted EPS of $-0.03 for Q4 2025.
EPS beat the consensus estimate of $-0.03 by $0.00.
Compared to the same quarter a year prior, diluted EPS grew 52.5% from $-0.06.
You can read the 10-K periodic report (0001493152-26-014376) directly on SEC EDGAR. The filing index links above go to sec.gov.